Press Releases
-
Elligo Health Research Announces Expansion of Study Marketplace With Syneos Health
Elligo Health Research®, the largest healthcare-enabling research organization, today announced it is expanding its Study Marketplace platform with Syneos Health, a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success.
Oct 5, 2023
-
Sharp acquires Berkshire Sterile Manufacturing
-
Veramed expands its global footprint by acquiring Data Management, Biostatistics and Medical Writing services company Clinical Trial Data Services (CTDS)
Specialist Biometrics CRO, Veramed, today announced the acquisition of Boston-based data management, biostatistics and medical writing company, CTDS.
Oct 4, 2023
-
Phastar Net-Zero Target Approved by the Science Based Targets Initiative
Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar commits to achieving Net-Zero Standard by 2035
Oct 3, 2023
-
BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa
Expert staff will be on hand at the conference to discuss how BioIVT can support CGT research from discovery and development to commercialization.
Oct 2, 2023
-
BioIVT to Host a Webinar on Optimizing Liquid Biopsy Research
This webinar will discuss the importance of using standardized collection protocols and a diverse donor base to validate biomarkers and ensure their clinical utility.
Oct 1, 2023
-
Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS
Takara Bio Inc. has announced that it has entered into a License Agreement with non-profit/charity organization, Telethon.
Oct 1, 2023
-
Emmes Introduces Telehealth Capabilities into Advantage eClinical
-
Alder Therapeutics set to redefine cell therapy development
Alder Therapeutics is set to reshape the cell therapy sector with a novel, reduced-risk approach to cell therapy development and two promising cell therapy candidates for diseases with high unmet need.
Sep 27, 2023
-
DNAnexus-enabled UK Biobank Research Analysis Platform Surpasses 5,000 Users in Two Years
The DNAnexus-enabled UK Biobank Research Analysis Platform community has grown to more than 5,000 users around the world.
Sep 27, 2023
-
Tower Cold Chain Accelerates Growth with Two New Senior Appointments for The Americas
Following the opening of its new Centre of Excellence facility to support further growth across the Americas, advanced temperature-controlled container specialist, Tower Cold Chain, has continued the expansion of its global team with the appointment of two senior leaders.
Sep 27, 2023
-
X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science
X-Chem, a global leader in innovative drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partnership dedicated to accelerating drug discovery through open science, announced that they have entered a collaboration aimed at creating new chemical tools to study human proteins.
Sep 27, 2023
-
Creative Proteomics Leads the Way with Cutting-Edge RNA Pull Down Service
-
Creative Proteomics Introduces Mature Solutions for Membrane Protein Identification
-
Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment
-
Creative Proteomics Launches State-of-the-Art Peptide Sequencing Service to Advance Proteomics Research
-
Cytel continues expansion of market access and medical communication capabilities with the acquisition of co.faktor
Cytel Inc. has acquired the Berlin-based company co.faktor GmbH.
Sep 26, 2023
-
Discovery Park selects 13 start-ups to join Discovery Spark life science programme
Thirteen life science start-ups have been accepted onto Discovery Park’s new business support programme and competition, Discovery Spark. The eight-week Discovery Spark programme will equip the early-stage companies with the necessary skills to catalyse their business growth plans and gives them the chance to win a business support package worth over £100,000.
Sep 26, 2023
-
Announcing Kivo GO: An intuitive DMS to accelerate speed-to-market for life sciences
Kivo today introduced Kivo GO, a unified platform for emerging life sciences teams who need to work together efficiently across all functions while maintaining compliance and security.
Sep 26, 2023
-
Sygnature Discovery successfully identifies potent SHP2 degrader compounds in collaboration with UBE Corporation